Insider trades
Jennifer Kayden Lee, EVP of Rhythm Pharmaceuticals RYTM, has filed 0 purchases and 35 sales on the open market. The latest trade was on 02/11.
Jennifer Kayden Lee
EVP, Head of North America
- Company
- Rhythm Pharmaceuticals RYTM
- First filing
- 23/02/03
- Trades
- 90 trades
- Buys / sales
- 0 / 35
- 12-month net buying
- No record
- Last trade
- 02/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 25/02/19 | 25/02/19 | 2,035 sh | $57.22 | $116,442.7 | −25.8% | |
RYTM | Open-market sale10b5-1 plan | 25/02/12–25/02/13 | 25/02/14 | 3,020 sh4 trades | $57.03avg. | $172,238.05 | −55.8% |
RYTM | Open-market sale10b5-1 plan | 25/02/10–25/02/11 | 25/02/11 | 5,216 sh4 trades | $58.63avg. | $305,838.69 | −49.1% |
RYTM | Open-market sale10b5-1 plan | 25/02/05 | 25/02/07 | 3,066 sh3 trades | $60.55avg. | $185,632.97 | −75.9% |
| Open-market sale | 25/02/04 | 25/02/04 | 1,447 sh | $59.43 | $85,995.21 | −26.4% | |
RYTM | Open-market sale10b5-1 plan | 24/11/11 | 24/11/13 | 66,861 sh4 trades | $66.33avg. | $4,435,067.88 | −98.6% |
RYTM | Open-market sale | 24/03/20 | 24/03/22 | 18,235 sh2 trades | $38.77avg. | $707,004.96 | −72.7% |
| Open-market sale | 24/03/19 | 24/03/19 | 15,515 sh | $39.22 | $608,498.3 | −38.2% | |
RYTM | Open-market sale | 24/02/12–24/02/13 | 24/02/13 | 1,638 sh2 trades | $50.80avg. | $83,207.19 | −19.3% |
| Open-market sale | 24/02/01 | 24/02/05 | 1,492 sh | $45.06 | $67,229.52 | −33.1% | |
| Open-market sale10b5-1 plan | 23/11/14 | 23/11/16 | 13,677 sh | $32.01 | $437,800.77 | −100.0% | |
RYTM | Open-market sale10b5-1 plan | 23/11/08–23/11/09 | 23/11/13 | 9,150 sh4 trades | $28.44avg. | $260,268.82 | −84.7% |
| Open-market sale10b5-1 plan | 23/11/03 | 23/11/07 | 80 sh | $28.00 | $2,240 | −4.6% | |
| Open-market sale10b5-1 plan | 23/09/05 | 23/09/07 | 6,166 sh | $28.05 | $172,956.3 | −78.9% | |
RYTM | Open-market sale10b5-1 plan | 23/08/07–23/08/09 | 23/08/09 | 12,941 sh2 trades | $24.24avg. | $313,738.02 | −79.7% |
RYTM | Open-market saleAmendment | 23/02/09–23/02/14 | 23/02/14 | 1,839 sh2 trades | $27.29avg. | $50,184.49 | −27.1% |
| Open-market sale | 23/02/09 | 23/02/13 | 1,192 sh | $27.66 | $32,970.72 | −25.1% |